Astronomer CEO’s ‘kiss cam’ controversy sparked over $7 million in prediction markets bets on his ouster

Jordi Vidal | Redferns | Getty Photos Astronomer CEO Andy Byron’s controversy went so viral that it sparked hundreds of thousands of {dollars} in bets on prediction markets over his resignation. On July 16, Byron was caught on digital camera hugging his human sources director Kristin Cabot on a kiss cam throughout a Coldplay live performance … Read more

What worries media mogul Rogers

Former NBC Cable President Tom Rogers is dialing again his bullishness on Netflix. The media trailblazer, who was a self-proclaimed “raging bull” on Netflix, instructed CNBC’s “Quick Cash” this week he is beginning to fear — and listed competitors with free content material on YouTube as a headwind. “[Netflix] nonetheless [has] extra hit reveals than … Read more

Artwork Cashin’s sons pay homage to NYSE legend by carrying on New 12 months’s poem custom

For many years, Artwork Cashin, UBS’ director of ground operations on the New York Inventory Trade, would write a New 12 months’s poem to mirror again on the 12 months’s occasions. With Cashin’s passing earlier this month, his sons, Arthur and Peter, despatched this homage to their father: Some Different Cashins’ Feedback:  An Homage PresentationDecember … Read more

State Street, Apollo team up to launch first of its kind private credit ETF

Omar Marques | Lightrocket | Getty Images There’s a new ETF in town. SPDR SSGA Apollo IG Public & Private Credit ETF (PRIV) will trade Thursday at the NYSE.  This fund intends to invest at least 80% of its net assets in investment grade debt securities, including a combination of public credit and private credit. What’s … Read more

Stocks making the biggest moves after hours: UAL, SRPT, MRCI

Check out the companies making headlines after the bell : United Airlines — Shares fell nearly 2% after the airline carrier posted a second-quarter revenue of $15.24 billion, missing analysts’ expectations of $15.35 billion, according to LSEG. Earnings, however, came in at $3.87 per share, exceeding the $3.81 consensus. Sarepta Therapeutics — The biopharma stock … Read more